ArticleCancer research communications2026
Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor-Resistant Patients in Clear Cell Renal Cell Carcinoma.
Hazem Abdullah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.